ArticleInternational journal of general medicine2026
Characterization of Gastric Mucinous Carcinoma: Clinicopathological Insights and Vascular Features via MSCT.
Article in International journal of general medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To compare the clinicopathologic characteristics, Multi-slice Spiral CT (MSCT) vascular features, and angiogenesis profiles among mucinous gastric carcinoma (MGC), gastric carcinoma with <50% extracellular mucin pool (LEMPC), and non-mucinous gastric carcinoma (NMGC), and to explore imaging-angiogenesis associations underlying subtype-specific enhancement patterns. Patients and Methods: Clinical, radiological, and pathological data from patients with MGC, LEMPC, and NMGC were analyzed in a three-group comparative design. Microvessel density (MVD) and the expression of vascular endothelial growth factor A (VEGF-A), hypoxia-inducible factor-1 alpha (HIF-1α), and epidermal growth factor (EGF) were evaluated by immunohistochemistry in cancerous and corresponding paracancerous normal tissues. Correlations between MSCT features and histopathological parameters were assessed. Results: Overall survival was lower in the MGC group than in the NMGC group ( Conclusion: MGCs, marked by poor differentiation and poor prognosis, exhibit intact mucosal lines, frequent calcification, and stratified enhancement on enhanced MSCT. Reduced MSCT enhancement indices are associated with low angiogenesis, concomitant with decreased VEGF-A and EGF expression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.